Form 4: uniQure CEO Sells Shares Under 10b5-1 Plan

uniQure N.V. CEO Matthew C. Kapusta executed a series of transactions involving the purchase and sale of company stock under a pre-arranged trading plan.

Summary

• Matthew C. Kapusta, CEO and Director of uniQure N.V., engaged in stock transactions on June 24th and June 25th, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on October 5th, 2025.
• Kapusta acquired 4,128 ordinary shares on June 24th at $31.71 per share and 28,716 ordinary shares on June 25th at $31.71 per share.
• Concurrently, Kapusta sold a total of 35,412 ordinary shares across these two days.
• On June 24th, 6,696 shares were sold at a weighted average price of $50.00, with individual sales ranging from $50.00 to $50.30.
• On June 25th, 28,716 shares were sold at a weighted average price of $50.02.
• Following these transactions, Kapusta beneficially owns 519,227 ordinary shares.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the significant sale of shares by the CEO, despite being executed under a 10b5-1 plan. While the plan itself is a standard practice, the volume of shares sold can be interpreted as a lack of immediate upside confidence by management.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-sensitive trading activity.
• The CEO continues to hold a significant number of shares (519,227) after the reported transactions.

Negatives

• The CEO sold a substantial number of shares (35,412) over two days.
• The sale price ($50.00-$50.30) is higher than the purchase price ($31.71) for the shares acquired and subsequently sold under the plan.

Risks

• The sale of a significant number of shares by a key executive could be perceived negatively by the market, potentially impacting share price.
• While executed under a 10b5-1 plan, the volume of sales might raise concerns about the executive's confidence in future stock performance.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
• The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• The Stock Option vested in full on January 25, 2023.

Industry Context

StockSavvy.ai notes that Form 4 filings by company insiders, particularly senior executives like CEOs, are closely watched by investors. Such filings can provide insights into management's perception of the company's valuation and future prospects. The use of a Rule 10b5-1 plan is a common strategy for executives to diversify their holdings or manage personal finances without triggering insider trading concerns, but the volume and timing of sales can still influence market sentiment.

Stakeholder Impact

• Shareholders: May interpret the CEO's stock sales as a negative signal, potentially leading to short-term price pressure. However, the use of a 10b5-1 plan mitigates some of these concerns.
• Employees: May be influenced by the CEO's trading activity, potentially affecting morale or their own investment decisions in company stock.
• Creditors: Unlikely to be directly impacted by this insider stock transaction.

Next Steps

• The reporting person will continue to adhere to the Rule 10b5-1 trading plan.
• The company may provide further information regarding the sales upon request from the SEC, shareholders, or the Issuer.

Key Dates

Recommendation

The filing reports routine stock transactions by the CEO under a pre-established 10b5-1 plan. While the sale of a significant number of shares warrants attention, the structured nature of the plan suggests it's not necessarily a reflection of negative future outlook. The company's underlying business performance, not detailed here, would be a more critical factor for a buy/sell decision. Therefore, a 'hold' recommendation is appropriate pending further fundamental analysis.

Keywords

uniQure, QURE, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Matthew C. Kapusta, SEC Filing, Beneficial Ownership, Stock Option